Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
JTO Clinical and Research Reports
|
September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC
Narek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
JCO Precision Oncology
|
March 18, 2026
Diffuse Pleural Mesothelioma in Young (Age ≤50 Years) and Very Young (Age ≤35 Years) Patients: Clinical Characteristics, Genomics, and Survival
Hely Ollila, Amina Tidjani, Jennifer L Sauter, et al.
European Journal of Radiology
|
April 15, 2024
Safety and efficacy of percutaneous cryoablation for primary and metastatic pleural based tumors
Erica S Alexander, Elena N Petre, Michael Offin, et al.
Annual Review of Pathology
|
September 18, 2023
Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment
Christopher A Febres-Aldana, Rachel Fanaroff, Michael Offin, et al.
The Journal of Trauma
|
August 10, 2011
Impact of enhanced mobilization of bone marrow derived cells to site of injury
Edward J Hannoush, Ziad C Sifri, Ihab O Elhassan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 10, 2020
Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers
Hiroki Sato, Michael Offin, Daisuke Kubota, et al.
Journal for Immunotherapy of Cancer
|
April 15, 2026
Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report
Hely Ollila, Prateek Kulkarni, Hyojin Kim, et al.
JTO Clinical and Research Reports
|
January 13, 2025
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
Prashasti Agrawal, Michael Offin, Victoria Lai, et al.
Blood Advances
|
June 29, 2018
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
Wenbin Xiao, Mariko Yabe, Michael Offin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 8, 2022
Multimodality Therapy in Patients With Primary Pericardial Mesothelioma
Michael Offin, Dilanka L De Silva, Jennifer L Sauter, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
JTO Clinical and Research Reports
|
September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC
Narek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
JCO Precision Oncology
|
March 18, 2026
Diffuse Pleural Mesothelioma in Young (Age ≤50 Years) and Very Young (Age ≤35 Years) Patients: Clinical Characteristics, Genomics, and Survival
Hely Ollila, Amina Tidjani, Jennifer L Sauter, et al.
European Journal of Radiology
|
April 15, 2024
Safety and efficacy of percutaneous cryoablation for primary and metastatic pleural based tumors
Erica S Alexander, Elena N Petre, Michael Offin, et al.
Annual Review of Pathology
|
September 18, 2023
Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment
Christopher A Febres-Aldana, Rachel Fanaroff, Michael Offin, et al.
The Journal of Trauma
|
August 10, 2011
Impact of enhanced mobilization of bone marrow derived cells to site of injury
Edward J Hannoush, Ziad C Sifri, Ihab O Elhassan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 10, 2020
Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers
Hiroki Sato, Michael Offin, Daisuke Kubota, et al.
Journal for Immunotherapy of Cancer
|
April 15, 2026
Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report
Hely Ollila, Prateek Kulkarni, Hyojin Kim, et al.
JTO Clinical and Research Reports
|
January 13, 2025
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
Prashasti Agrawal, Michael Offin, Victoria Lai, et al.
Blood Advances
|
June 29, 2018
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
Wenbin Xiao, Mariko Yabe, Michael Offin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 8, 2022
Multimodality Therapy in Patients With Primary Pericardial Mesothelioma
Michael Offin, Dilanka L De Silva, Jennifer L Sauter, et al.
Page
of 9